China Longevity Group Company Limited (Stock Code: 1863) reported a continued suspension of share trading on the Hong Kong Stock Exchange since 14 February 2013. The company stated that its production, operation, and finance remain healthy, with an ongoing focus on the research and development of new materials and products.

According to the announcement, the Stock Exchange previously confirmed withholding action to delist the company under Rule 6.01A(2)(b)(ii) as long as the suspension remained in effect on 31 July 2019. As of the date of this update, no formal delisting notice has been received.

On regulatory matters, the company submitted a written representation to address the concerns outlined in a “Show Cause Letter” dated 24 November 2014 from the Securities and Futures Commission. The Commission’s Board has considered the submission but has adjourned its decision, potentially requesting further information from the company. Trading in the company’s shares will remain suspended until further notice.